Star Combo (Australia) Insiders
S66 Stock | 0.15 0.01 7.14% |
Star Combo employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Star Combo's management performance can provide insight into the firm performance.
Su MBA CEO CEO Director |
Star |
Star Combo Management Team Effectiveness
The company has return on total asset (ROA) of 0.0136 % which means that it generated a profit of $0.0136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0224 %, meaning that it generated $0.0224 on every $100 dollars invested by stockholders. Star Combo's management efficiency ratios could be used to measure how well Star Combo manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Star Combo's Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 1.2 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 4.3 M in 2025.Common Stock Shares Outstanding is likely to drop to about 113.3 M in 2025. Net Loss is likely to gain to about (3.4 M) in 2025
Star Combo Workforce Comparison
Star Combo Pharma is currently under evaluation in number of employees category among its peers. The total workforce of Consumer Staples industry is at this time estimated at about 32,126. Star Combo adds roughly 0.0 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. Star Combo Pharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Star Combo Pharma Price Series Summation is a cross summation of Star Combo price series and its benchmark/peer.
Star Combo Notable Stakeholders
A Star Combo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Star Combo often face trade-offs trying to please all of them. Star Combo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Star Combo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
JinXing BS | MD Founder | Profile | |
Su MBA | CEO Director | Profile | |
James Ni | Chief Officer | Profile | |
He BS | Chief Officer | Profile | |
FACID FAICD | Company Sec | Profile |
About Star Combo Management Performance
The success or failure of an entity such as Star Combo Pharma often depends on how effective the management is. Star Combo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Star management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Star management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Star Combo is entity of Australia. It is traded as Stock on AU exchange.
Please note, the imprecision that can be found in Star Combo's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Star Combo Pharma. Check Star Combo's Beneish M Score to see the likelihood of Star Combo's management manipulating its earnings.
Star Combo Workforce Analysis
Traditionally, organizations such as Star Combo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Star Combo within its industry.Star Combo Manpower Efficiency
Return on Star Combo Manpower
Revenue Per Employee | 5.2M | |
Revenue Per Executive | 5.2M | |
Net Income Per Employee | 149.5K | |
Net Income Per Executive | 149.5K | |
Working Capital Per Employee | 2.8M | |
Working Capital Per Executive | 2.8M |
Additional Tools for Star Stock Analysis
When running Star Combo's price analysis, check to measure Star Combo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Combo is operating at the current time. Most of Star Combo's value examination focuses on studying past and present price action to predict the probability of Star Combo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Combo's price. Additionally, you may evaluate how the addition of Star Combo to your portfolios can decrease your overall portfolio volatility.